Author:
Suissa Samy,Dell’Aniello Sophie,Ernst Pierre
Funder
Canada Foundation for Innovation
Canadian Institutes of Health Research
Subject
Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine
Reference25 articles.
1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary;Rabe;Am J Respir Crit Care Med,2007
2. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary;Vogelmeier;Eur Respir J,2017
3. Inhaled corticosteroids in COPD: the clinical evidence;Ernst;Eur Respir J,2015
4. Long-acting muscarinic antagonist (LAMA) plus long-acting β-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD);Horita;Cochrane Database Syst Rev,2017
5. Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study;Vogelmeier;Lancet Respir Med,2013
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献